Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

Abroad (travel likely)RecruitingPHASE3

Conditions

Multiple Myeloma · Relapse Multiple Myeloma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Service d'hématologie clinique et thérapie cellulaire, Saint-Antoine Hospital, Paris, France
Contact: Study coordinator (Florent MALARD, PU-PH) · florent.malard@aphp.fr · 01 49 28 34 39
Contact: Study coordinator (Mohamad MOHTY, PU-PH) · mohamad.mohty@inserm.fr · 01 49 28 26 20

Study leads

Mohamad MOHTY, PU-PH
Principal Investigator
Assistance Publique - Hôpitaux de Paris

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

Multiple Myeloma

IsraelRecruitingPHASE3

Jupiter, United States · Basking Ridge, United States

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

Relapse Multiple Myeloma · Refractory Multiple Myeloma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Madison, United States

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Multiple Myeloma

Abroad (travel likely)RecruitingPHASE2

Tucson, United States · Denver, United States

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

Myeloma · Non-Hodgkin's Lymphoma · Leukemia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Adelaide, Australia · Melbourne, Australia